Digital Marketing Trends in Non-small Cell Lung Cancer

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Digital Marketing Trends in Non-small Cell Cancer Report Overview

Merck’s Keytruda.com achieved the highest total traffic across Non-small Cell Lung Cancer (NSCLC) patient sites in the US from October 2022 to September 2023. This was followed by BMS’s Opdivo.com and AstraZeneca’s Imfinzi.com. Keytruda.com was also supported by the most paid search engine optimization (SEO) at over 7,600 keywords, closely followed by Enhertu.com and Opdivo.com. Overall, the highest proportion of traffic to top branded patient NSCLC websites originated from direct and organic sources.

The Digital Marketing Trends in the Non-small Cell Cancer research report assesses key digital marketing metrics of pharma assets in CRC, including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction.

Key US Patient-Branded Websites ·        Keytruda.com

·        Opdivo.com

·        Imfinzi.com

·        Enhertu.com

·        Avastin.com

·        Libtayo.com

Key US HCP Branded Websites ·        Keytrudahcp.com

·        Imfinzihcp.com

·        Lumakrashcp.com

·        Libtayohcp.com

·        Tagrissohcp.com

·        Enhertuhcp.com

Key EUCAN Unbranded Websites ·        Daskwort.de

·        Pactonco.fr

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Major US Patient Branded Websites for Non-small Cell Cancer

The major US patient-branded websites for Non-small Cell Cancer are Keytruda.com, Opdivo.com, Imfinzi.com, Enhertu.com, Avastin.com, and Libtayo.com. Merck’s Keytruda.com achieved the highest total traffic across NSCLC patient sites in the US from October 2022 to September 2023. This was followed by BMS’s Opdivo.com  and AstraZeneca’s Imfinzi.com.

Traffic Share to Branded US CRC Patient Sites, October 2022 – September 2023 (%)

Traffic Share to Branded US CRC Patient Sites, October 2022 - September 2023 (%)

 Buy the Full Report for More into Total Traffic Share Insights of the US Patient-Branded Websites Download a Free Report Sample

Major US HCP Branded Websites for Non-small Cell Cancer

The major US HCP-branded websites for Non-small Cell Cancer are Keytrudahcp.com, Imfinzihcp.com, Lumakrashcp.com, Libtayohcp.com, Tagrissohcp.com, and Enhertuhcp.com. AstraZeneca’s Imfinzihcp.com achieved the highest total traffic across NSCLC HCP sites in the US from October 2022 to September 2023. This was followed by Merck’s Keytrudahcp.com.

Traffic Share to Branded US CRC HCP Sites, October 2022 – September 2023 (%)

Traffic Share to Branded US CRC HCP Sites, October 2022 - September 2023 (%)

Buy the Full Report for More Insights into The Total Traffic Share of The US HCP Branded Websites

Download a Free Report Sample

Major EUCAN Unbranded Websites for Non-small Cell Cancer

Roche’s Daskwort.de achieved the highest total traffic across NSCLC unbranded sites in EUCAN from October 2022 to September 2023. It was followed by Pfizer’s Pactonco.fr. Overall, the highest proportion of traffic to branded NSCLC websites for unbranded websites originated from organic sources, followed by direct.

Buy the Full Report for More Insights into The Total Traffic Share of the EUCAN-Unbranded Websites

Download a Free Report Sample

Scope

  • This report assesses key digital marketing metrics of pharma assets in NSCLC, including branded websites for patients and HCPs, Unbranded websites, and social media accounts.
  • Metrics include website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
  • Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).

Reasons to Buy

  • Understand the digital marketing competitive landscape in NSCLC, with a view to leading patient and HCP branded assets across different regions.
  • See what tactics pharma companies are using to drive traffic to their NSCLC branded assets for patients and HCPs, such as DDA and paid SEO.
  • Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
  • Compare top branded and unbranded assets for patients by how they address and support different patient needs.
  • See what pharma social media accounts in PsO are the most active and achieving the most engagement.

Merck
BMS
AstraZeneca
Pfizer
Regeneron
Roche

Table of Contents

Executive Summary

US Branded Sites for Patients

US Branded Websites for HCPs

US Unbranded Sites

EUCAN Unbranded Websites

Appendix

Frequently asked questions

Digital Marketing Trends in Non-small Cell Lung Cancer thematic reports
Currency USD
$1,950

Can be used by individual purchaser only

$3,900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Digital Marketing Trends in Non-small Cell Lung Cancer was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Digital Marketing Trends in Non-small Cell Lung Cancer in real time.

  • Access a live Digital Marketing Trends in Non-small Cell Lung Cancer dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.